clinical trial · NCT05745883
Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
Chronic Kidney DiseasesAnemia of Chronic Kidney DiseaseDISC-0974Placebo
brief summary
This Phase 1b study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney Disease and Anemia.
started
Apr 4, 2023
primary completion
Oct 9, 2025
completion
Jan 16, 2026
last updated
Apr 22, 2026
official title
A Phase 1b Multicenter, Randomized, Double-Blind, Placebo-Controlled Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DISC-0974 in Participants With Non-Dialysis Dependent Chronic Kidney Disease and Anemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol